Ekso Bionics Holdings, Inc.
NASDAQ:EKSO
0.8903 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||
Net Income
| -15.198 | -15.08 | -9.764 | -15.825 | -12.132 | -26.992 | -29.122 | -23.47 | -19.59 | -33.769 | -0.012 |
Depreciation & Amortization
| 1.698 | 0.887 | 0.561 | 0.62 | 0.69 | 1.515 | 1.732 | 1.855 | 0.933 | 0.745 | 0 |
Deferred Income Tax
| -7.537 | 0 | -4.119 | 2.429 | -5.868 | -0.606 | -3.237 | -4.151 | -2.505 | 16.485 | 0 |
Stock Based Compensation
| 2.236 | 2.732 | 2.5 | 2.579 | 2.397 | 3.08 | 2.923 | 3.121 | 1.731 | 1.143 | 0 |
Change In Working Capital
| -0.583 | -2.58 | -0.468 | 1.123 | -2.019 | 0.53 | -3.577 | -2.15 | 0.678 | 0.23 | 0 |
Accounts Receivables
| -1.208 | -0.067 | -1.624 | 1.754 | -1.599 | -0.85 | -1.085 | 0.154 | -0.52 | -1 | 0 |
Inventory
| 0.232 | -1.4 | -0.752 | 0.379 | 0.893 | -1.655 | -2.096 | -0.541 | -0.2 | 0.354 | 0 |
Accounts Payables
| -1.307 | -0.102 | 1.612 | -0.402 | -1.231 | 0.752 | 0.077 | -0.818 | 1.738 | -0.716 | 0 |
Other Working Capital
| 1.7 | -1.011 | 0.296 | -0.608 | -0.082 | 2.283 | -0.473 | -0.945 | -0.34 | 1.592 | 0 |
Other Non Cash Items
| 7.33 | -0.647 | 0.134 | 0.319 | 1.16 | 0.308 | 0.055 | -0.202 | 0.484 | 0.159 | 0 |
Operating Cash Flow
| -12.054 | -14.688 | -11.156 | -8.755 | -15.772 | -22.165 | -31.226 | -24.997 | -18.269 | -15.007 | -0.012 |
Investing Activities: | |||||||||||
Investments In Property Plant And Equipment
| -0.157 | -0.194 | -0.059 | 0 | -0.06 | -0.131 | -0.456 | -1.096 | -1.492 | -1.487 | 0 |
Acquisitions Net
| 0 | -5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Investing Activites
| -0.157 | 0.019 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investing Cash Flow
| -0.157 | -5.175 | -0.059 | 0 | -0.06 | -0.131 | -0.456 | -1.096 | -1.492 | -1.487 | 0 |
Financing Activities: | |||||||||||
Debt Repayment
| -0.313 | 0 | 0 | -2.79 | -2.377 | -2.174 | -0.054 | -0.079 | -0.06 | -2.596 | 0 |
Common Stock Issued
| 0.661 | 0.176 | 37.295 | 7.082 | 21.188 | 4.446 | 42.463 | 14.694 | 0 | 21.961 | 0.027 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.173 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10.345 | 0 | 0 | 0 |
Other Financing Activities
| -0.313 | -0.176 | 1.417 | 6.412 | 0.228 | 0.001 | 0.159 | 19.21 | 14.183 | 21.514 | 0.006 |
Financing Cash Flow
| 0.348 | 0.176 | 38.712 | 10.704 | 19.039 | 2.273 | 42.568 | 23.307 | 14.123 | 40.879 | 0.033 |
Other Information: | |||||||||||
Effect Of Forex Changes On Cash
| -0.024 | -0.018 | 0.047 | 0.041 | 0.01 | -0.135 | 0.081 | 0.08 | 0 | 0 | 0 |
Net Change In Cash
| -11.887 | -19.881 | 27.544 | 1.99 | 3.217 | -20.158 | 10.967 | -2.706 | -5.638 | 24.385 | 0.021 |
Cash At End Of Period
| 8.638 | 20.525 | 40.406 | 12.862 | 10.872 | 7.655 | 27.813 | 16.846 | 19.552 | 25.19 | 0.029 |